These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3136067)

  • 1. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
    Franks S; Sagle M; Mason HD; Kiddy D
    Horm Res; 1987; 28(2-4):164-8. PubMed ID: 3136067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
    Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS
    Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
    Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GnRH agonist administration in polycystic ovary syndrome.
    Buckler HM; Phillips SE; Kovacs GT; Burger HG; Healy DL
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):151-65. PubMed ID: 2514053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
    Nakamura Y; Yoshimura Y; Tamaoka Y; Ubukata Y; Yoshida K; Yamada H; Iizuka R; Suzuki M
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):395-402. PubMed ID: 3150824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
    Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
    J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
    Ito T; Michioka T; Kobayashi M; Narimatsu A; Yamashita S; Matsuzaki H; Kuramoto T; Numa F; Yakabe A
    Horm Res; 1990; 33 Suppl 2():32-4. PubMed ID: 2128879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.
    Donderwinkel PF; Schoot DC; Pache TD; de Jong FH; Hop WC; Fauser BC
    Hum Reprod; 1993 Dec; 8(12):2027-32. PubMed ID: 8150898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The choice of treatment for anovulation associated with polycystic ovary syndrome following failure to conceive with clomiphene.
    Farhi J; Homburg R; Lerner A; Ben-Rafael Z
    Hum Reprod; 1993 Sep; 8(9):1367-71. PubMed ID: 8253919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian sensitivity to gonadotrophins in patients with PCO is unaffected by suppression of LH.
    Fleming R; Hamilton MP; Conaghan C; Black WP; Coutts JR
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):33-8. PubMed ID: 2110046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
    Hamori M; Zwirner M; Clédon P; Tinneberg HR
    Int J Fertil; 1992; 37(3):171-5. PubMed ID: 1355764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist.
    Gadir AA; Alnaser HM; Mowafi RS; Shaw RW
    Fertil Steril; 1992 Feb; 57(2):309-13. PubMed ID: 1735480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome.
    Emperaire JC; Ruffie A
    Hum Reprod; 1991 Apr; 6(4):506-10. PubMed ID: 1918298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
    Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
    Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.
    Balasch J; Fábregues F; Casamitjana R; Peñarrubia J; Vanrell JA
    Reprod Biomed Online; 2003; 6(3):296-301. PubMed ID: 12735863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
    Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J
    Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.
    Hompes PG; van Weissenbruch MM; Burger CW; Schoemaker J
    Prog Clin Biol Res; 1986; 225():391-9. PubMed ID: 3097674
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
    Homburg R; Levy T; Ben-Rafael Z
    Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.